| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals, Inc. (TARS) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. TARS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.5K | $52.55M | - | |
| Dir | 128.8K | $7.89M | - | |
| COO | 79.2K | $4.85M | - | |
| Other | 47.6K | $2.91M | - | |
| Other | 36.7K | $2.25M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $18.63 | $149,040.00 | -0.8% | -7.4% | +43.8% | |
| Jun 14, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 9,000 | $18.58 | $167,220.00 | -0.9% | -11.6% | +78.3% | |
| Jun 8, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 3,100 | $20.01 | $62,031.00 | -0.3% | -17.7% | +64.0% | |
| Jun 8, 2023 | Mottiwala Aziz51 | Chief Commercial Officer | Sell | 100 | $20.00 | $2,000.00 | -0.2% | -17.7% | +64.0% | |
| Jun 7, 2023 | Mottiwala Aziz51 | Chief Commercial Officer | Sell | 4,643 | $19.00 | $88,231.23 | -4.5% | -13.0% | +69.0% | |
| May 17, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $15.90 | $127,200.00 | -0.8% | +6.7% | +142.2% | |
| May 10, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 9,000 | $16.80 | $151,200.00 | -0.8% | +1.4% | +103.8% | |
| May 1, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 10,119 | $15.11 | $152,925.24 | -0.5% | +44.6% | +106.5% | |
| Apr 21, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 2,311 | $15.03 | $34,734.33 | -0.2% | +55.5% | +117.0% | |
| Apr 20, 2023 | Greenstein Leonard M. | Chief Financial Officer | Sell | 5,000 | $14.02 | $70,100.00 | -15.7% | +38.9% | +124.0% |